跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CREDANIL 25/100 TABLET - HSA Drug Approval Details
Approvals
/
HSA
/
CREDANIL 25/100 TABLET
Approved
THERAPEUTIC
CREDANIL 25/100 TABLET
REMEDICA LTD
🇸🇬 Health Sciences Authority
Approval Date
Oct 14, 1998
Approval ID
735eb3b85fa5397d
Company
REMEDICA LTD
Type
Therapeutic
Approval Details
Approval Id
735eb3b85fa5397d
Drug Name
CREDANIL 25/100 TABLET
Product Name
CREDANIL 25/100 TABLET
Approval Number
SIN10285P
Approval Date
1998-10-14
Registrant
GOLDPLUS UNIVERSAL PTE LTD
Licence Holder
GOLDPLUS UNIVERSAL PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
N04BA02
Atc Item Name
levodopa and decarboxylase inhibitor
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Company Detail Path
/organization/goldplus-universal-pte-ltd
Active Ingredients
CARBIDOPA MONOHYDRATE EQV CARBIDOPA
25 mg
LEVODOPA
100 mg
CARBIDOPA MONOHYDRATE EQV CARBIDOPA
25 MG
LEVODOPA
100 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Oct 14, 1998
Approval ID
735eb3b85fa5397d
Type
Therapeutic
Back to HSA Approvals